InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Sarepta Therapeutics, Inc.

SRPT Clue Score48
United States Fiscal year ends December CIK 0000873303 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

63
Insider
Date
Role
Action
Shares
Price
Amount
Claude Nicaise
12 Mar 2025
Director
Sold after exercise
2,491
$99.64
$248.20K
Hans Lennart Rudolf Wigzell
12 Dec 2024
Director
Sold after exercise
10,500
$124.84
$1.31M
Ryan Edward Brown
25 Jun 2024
EVP, General Counsel
Sold after exercise
2,549
$164.52
$419.36K
Ryan Edward Brown
25 Jun 2024
EVP, General Counsel
Sold after exercise
3,840
$163.53
$627.96K
Ryan Edward Brown
25 Jun 2024
EVP, General Counsel
Sold after exercise
17,581
$162.65
$2.86M
Ryan Edward Brown
25 Jun 2024
EVP, General Counsel
Sold after exercise
4,168
$161.82
$674.47K
Ryan Edward Brown
25 Jun 2024
EVP, General Counsel
Sold after exercise
975
$160.31
$156.30K
Ryan Edward Brown
25 Jun 2024
EVP, General Counsel
Sold after exercise
2,200
$159.14
$350.11K
Ryan Edward Brown
25 Jun 2024
EVP, General Counsel
Sold after exercise
7,644
$158.07
$1.21M
Hans Lennart Rudolf Wigzell
8 Mar 2024
Director
Sold after exercise
100
$122.39
$12.24K
Hans Lennart Rudolf Wigzell
8 Mar 2024
Director
Sold after exercise
11,745
$123.10
$1.45M
Hans Lennart Rudolf Wigzell
8 Mar 2024
Director
Sold after exercise
3,155
$123.85
$390.75K
Hans Lennart Rudolf Wigzell
4 Aug 2023
Director
Sold after exercise
15,000
$106.72
$1.60M
M Kathleen Behrens
10 Mar 2021
Director
Sold after exercise
5,000
$85.76
$428.80K
Hans Lennart Rudolf Wigzell
8 Mar 2021
Director
Sold after exercise
10,000
$83.51
$835.10K
Joseph Bratica
11 Dec 2020
Principal Financial Officer
Sold after exercise
1,115
$165.00
$183.98K
Joseph Bratica
8 Dec 2020
Principal Financial Officer
Sold after exercise
1,125
$160.00
$180.00K
Hans Lennart Rudolf Wigzell
10 Aug 2020
Director
Sold after exercise
777
$159.65
$124.05K
Hans Lennart Rudolf Wigzell
10 Aug 2020
Director
Sold after exercise
9,223
$158.95
$1.47M
Joseph Bratica
3 Aug 2020
Principal Financial Officer
Sold after exercise
1,125
$155.00
$174.38K
David T Howton
22 Jun 2020
EVP, General Counsel
Sold after exercise
55,270
$171.50
$9.48M
David T Howton
22 Jun 2020
EVP, General Counsel
Sold after exercise
35,757
$170.59
$6.10M
David T Howton
22 Jun 2020
EVP, General Counsel
Sold after exercise
8,086
$169.56
$1.37M
David T Howton
22 Jun 2020
EVP, General Counsel
Sold after exercise
6,009
$168.61
$1.01M
Hans Lennart Rudolf Wigzell
20 May 2020
Director
Sold after exercise
854
$151.77
$129.61K
Hans Lennart Rudolf Wigzell
20 May 2020
Director
Sold after exercise
2,046
$151.22
$309.40K
Hans Lennart Rudolf Wigzell
20 May 2020
Director
Sold after exercise
2,100
$149.62
$314.20K
Hans Lennart Rudolf Wigzell
4 Mar 2020
Director
Sold after exercise
5,000
$116.89
$584.45K
Sandesh Mahatme
13 Dec 2019
EVP, CFO & Cbo
Sold after exercise
125,000
$125.50
$15.69M
David T Howton
13 Dec 2019
EVP, General Counsel
Sold after exercise
78,000
$125.50
$9.79M
Alexander Cumbo
13 Dec 2019
EVP, Chief Commercial Officer
Sold after exercise
9,294
$125.50
$1.17M
Alexander Cumbo
13 Dec 2019
EVP, Chief Commercial Officer
Sold after exercise
32,706
$125.50
$4.10M
David T Howton
22 Nov 2019
EVP, General Counsel
Sold after exercise
2,957
$105.00
$310.49K
David T Howton
22 Nov 2019
EVP, General Counsel
Sold after exercise
3,753
$105.00
$394.07K
David T Howton
22 Nov 2019
EVP, General Counsel
Sold after exercise
18,290
$105.00
$1.92M
Hans Lennart Rudolf Wigzell
23 May 2019
Director
Sold after exercise
10,000
$120.00
$1.20M
Sandesh Mahatme
7 Feb 2019
EVP, CFO & Cbo
Sold after exercise
65,000
$145.00
$9.43M
David T Howton
1 Feb 2019
SVP, General Counsel
Sold after exercise
30,000
$140.00
$4.20M
Alexander Cumbo
1 Feb 2019
SVP, Chief Commercial Officer
Sold after exercise
15,000
$140.00
$2.10M
Sandesh Mahatme
31 Jan 2019
EVP, CFO & Cbo
Sold after exercise
21,198
$130.72
$2.77M
Sandesh Mahatme
30 Jan 2019
EVP, CFO & Cbo
Sold after exercise
43,802
$130.00
$5.69M
Hans Lennart Rudolf Wigzell
1 Nov 2018
Director
Sold after exercise
6,667
$140.50
$936.71K
M Kathleen Behrens
31 Oct 2018
Director
Sold after exercise
10,000
$131.71
$1.32M
Sandesh Mahatme
24 Oct 2018
EVP, CFO & Cbo
Sold after exercise
107,524
$127.74
$13.74M
David T Howton
16 Jul 2018
SVP, General Counsel
Sold after exercise
37,848
$136.46
$5.16M
David T Howton
16 Jul 2018
SVP, General Counsel
Sold after exercise
9,056
$136.46
$1.24M
David T Howton
16 Jul 2018
SVP, General Counsel
Sold after exercise
3,096
$136.46
$422.48K
Alexander Cumbo
9 Jul 2018
SVP, Chief Commercial Officer
Sold after exercise
11,914
$137.32
$1.64M
Alexander Cumbo
9 Jul 2018
SVP, Chief Commercial Officer
Sold after exercise
9,944
$137.32
$1.37M
Alexander Cumbo
9 Jul 2018
SVP, Chief Commercial Officer
Sold after exercise
11,924
$137.32
$1.64M
Hans Lennart Rudolf Wigzell
30 Nov 2017
Director
Sold after exercise
6,667
$55.89
$372.62K
Shamim Ruff
6 Nov 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
10,000
$55.00
$550.00K
Shamim Ruff
3 Oct 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
11,500
$50.00
$575.00K
Shamim Ruff
21 Jul 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
1,500
$44.00
$66.00K
Shamim Ruff
21 Jul 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
4,388
$44.00
$193.07K
Alexander Cumbo
20 Jul 2017
SVP, Chief Commercial Officer
Sold after exercise
3,418
$41.00
$140.14K
Alexander Cumbo
20 Jul 2017
SVP, Chief Commercial Officer
Sold after exercise
2,500
$41.00
$102.50K
David T Howton
20 Jul 2017
SVP, General Counsel
Sold after exercise
5,944
$41.00
$243.70K
David T Howton
20 Jul 2017
SVP, General Counsel
Sold after exercise
19,056
$41.00
$781.30K
Shamim Ruff
20 Jul 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
6,250
$42.00
$262.50K
Sandesh Mahatme
20 Jul 2017
EVP, CFO & Cbo
Sold after exercise
7,627
$41.00
$312.71K
Sandesh Mahatme
20 Jul 2017
EVP, CFO & Cbo
Sold after exercise
32,998
$41.00
$1.35M
Sandesh Mahatme
20 Jul 2017
EVP, CFO & Cbo
Sold after exercise
9,375
$41.00
$384.38K
Show all 167 transactions →

What was left out

Form 4 filings counted 327
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 63
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 4,825,682
Sales filed before the plan box existed 7
History held since 8 Feb 2007